• Amikacin Sulfate: Protocols and Precision Delivery in NTM Re

  2026-06-25

  Amikacin Sulfate empowers researchers to achieve targeted, high-efficacy bactericidal action against challenging non-tuberculous mycobacterial (NTM) pathogens. This guide translates bench research into actionable workflows, with troubleshooting strategies and translational insights for maximizing intracellular and in vivo performance.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Sensitive Mouse IgG

  2026-06-25

  The Cy5 Goat Anti-Mouse IgG (H+L) Antibody is a high-sensitivity, Cy5-conjugated secondary antibody optimized for fluorescent detection of mouse IgG. It offers robust signal amplification in immunohistochemistry, immunocytochemistry, and flow cytometry, with validated specificity and workflow compatibility.

• SLC7A14 in Hypothalamic POMC Neurons Regulates Age-Related L

  2026-06-24

  This study identifies SLC7A14 as a critical regulator of age-induced reduction in lipolysis in white adipose tissue (WAT) via hypothalamic POMC neurons. The mechanistic pathway elucidated here connects central neural regulation, bile acid metabolism, and mTORC1 signaling, providing new insight into the brain–gut–adipose tissue axis in metabolic aging.

• BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lipid

  2026-06-23

  BODIPY 581/591 C11 sets the standard for ratiometric fluorescent lipid peroxidation detection in live cells. Its spectral shift and high specificity streamline workflows for oxidative stress measurement and antioxidant evaluation, empowering translational research in ferroptosis and bone health.

• Amikacin Sulfate Workflows for Targeted NTM Infection Resear

  2026-06-23

  Amikacin Sulfate stands out in mycobacterial research for its proven ability to achieve high, targeted bactericidal activity within granulomas while minimizing systemic toxicity. Leveraging innovative delivery through dendritic cells and robust protocol parameters, this guide unpacks experimental workflows and troubleshooting strategies that maximize translational impact.

• Tiamulin (Thiamutilin): Advanced Workflows for Infection & I

  2026-06-22

  Tiamulin (Thiamutilin) delivers robust, dual-action efficacy for both bacterial infections and TNF-α-driven inflammation in veterinary and research settings. This guide details quantitative, workflow-optimized protocols, real-world troubleshooting, and insights from the latest reference study—empowering researchers to maximize reproducibility and translational impact.

• Reliable Cell Assays with Recombinant Human FGF-19 (E.coli,

  2026-06-22

  This article addresses key challenges in cell viability and proliferation assays by demonstrating how Recombinant Human FGF-19 (E.coli, Tag Free, Lyophilized) (SKU P1050) delivers reproducible, biologically validated results. Scenario-driven guidance and quantitative data illustrate its advantages for metabolic regulation research, FGF-19/FGFR4 pathway studies, and workflow optimization.

• Cefiderocol Efficacy Against Resistant Enterobacterales in E

  2026-06-21

  This study provides a comprehensive in vitro analysis of cefiderocol activity against a large, pan-European collection of Enterobacterales, including isolates resistant to meropenem and β-lactam/β-lactamase inhibitors. The findings demonstrate that cefiderocol retains high activity where many alternative antibiotics fail, guiding therapeutic choices for multidrug-resistant infections.

• Tiamulin (Thiamutilin): Precision Protocols for Veterinary R

  2026-06-20

  Tiamulin (Thiamutilin) uniquely combines antibacterial and anti-inflammatory capabilities, making it indispensable for both infectious disease control and translational inflammation models in veterinary science. This article delivers actionable protocols, troubleshooting insights, and new directions for researchers leveraging APExBIO’s rigorously characterized Tiamulin.

• Amikacin Sulfate: Precision Tools for Next-Gen NTM Research

  2026-06-19

  Explore the mechanistic depth and translational frontiers of Amikacin Sulfate for non-tuberculous mycobacterial (NTM) infection models. This article bridges molecular pharmacology, intracellular delivery, and strategic protocol design, offering actionable guidance for researchers seeking to optimize efficacy and minimize toxicity in advanced infectious disease workflows.

• Engineered mRNA Treatment Rescues Niemann-Pick C1 Phenotype

  2026-06-19

  The referenced study demonstrates that combining GC3 codon optimization with N1-Methylpseudouridine modification dramatically improves mRNA potency and enables correction of the pathogenic cellular phenotype in Niemann-Pick disease type C1 fibroblasts. These findings validate advanced mRNA engineering strategies for protein replacement in monogenic disorders.

• PBS Liposomes: Optimizing Macrophage Depletion Controls in V

  2026-06-18

  PBS Liposomes from APExBIO offer a robust, inert control for macrophage depletion assays, ensuring reliable baseline measurements in comparative studies. This guide explores validated workflows, advanced applications, and troubleshooting strategies for maximizing reproducibility in in vivo immune modulation experiments.

• Targeting AR and ARv7 in TNBC: EPI-001 Modulates Metastatic

  2026-06-18

  This study identifies androgen receptor (AR) and its splice variant ARv7 as markers of poor prognosis and metastasis in triple-negative breast cancer (TNBC). Targeting these receptors with the N-terminal domain inhibitor EPI-001 disrupts key pathways involved in metastasis and epithelial-mesenchymal transition, offering mechanistic insight for developing AR-targeted interventions in TNBC.

• Eldecalcitol Reduces Endothelial Ferroptosis in Diabetic Ost

  2026-06-17

  This study demonstrates that eldecalcitol mitigates type 2 diabetic osteoporosis by suppressing endothelial cell ferroptosis via the SOCE/O-GlcNAcylation signaling axis. The research provides mechanistic insight into vascular-bone coupling and highlights advanced approaches for lipid peroxidation detection in disease models.

• TTP Modulates m6A Methylation to Attenuate Schistosomiasis F

  2026-06-17

  This study uncovers a novel mechanism by which tristetraprolin (TTP) ameliorates schistosomiasis-induced liver fibrosis through the epitranscriptomic regulation of TGF-β1 mRNA stability via m6A methylation. The findings highlight a potential therapeutic strategy targeting TTP-mediated RNA methylation pathways to inhibit hepatic stellate cell activation and fibrotic progression.

15915 records 1/1061 page Next 12345 下5页 Last page